Skip to content
Quebec News Tribune – Lifestyle
Author:
Sol-Gel Technologies Ltd.
Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome
September 17, 2026
Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 28, 2026
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering
March 23, 2026